FOLH1 and neoplasm: The tumor volume of the PSMA-targeted PFP@IR780@PTX@liposome plus LIFU irradiation group was increased by only 15.03% compared with that of the control group (597.15%), which was significantly lower than that of the PSMA-targeted PFP@IR780@PTX@liposome group, PTX group and PBS+LIFU group (Figure 6B).